Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Middle East Pharmaceutical Industries CoSAU:4016 +0.92%22 Dividend Payout Ratio is 0.98 as of Mar. 2026, which is 188% above its 10-year median of 0.34. GuruFocus rates SAU:4016 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 445 Drug Manufacturers companies, Middle East Pharmaceutical Industries Co ranks worse than 81.57% on this metric.
SAU:4016's Dividend Payout Ratio is ranked worse than 81.57% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs SAU:4016: 0.70
During the past 3 years, the highest Trailing Annual Dividend Yield of Middle East Pharmaceutical Industries Co was 3.75%. The lowest was 0.55%. And the median was 1.64%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Middle East Pharmaceutical Industries Co (SAU:4016) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Middle East Pharmaceutical Industries Co Dividend Payout Ratio Related Terms
Middle East Pharmaceutical Industries Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co Dividend Payout Ratio Chart
Middle East Pharmaceutical Industries Co Annual Data
Trend
Dec23
Dec24
Dec25
Dividend Payout Ratio
0.00
0.19
0.49
Middle East Pharmaceutical Industries Co Quarterly Data
SAU:4016 vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Pharmaceutical Industries Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Middle East Pharmaceutical Industries Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Middle East Pharmaceutical Industries Co's Dividend Payout Ratio falls into.
Middle East Pharmaceutical Industries Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co (SAU:4016) has a Dividend Payout Ratio of 0.98 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Middle East Pharmaceutical Industries Co and its competitors. This is 188% above median its historical median of 0.34. Over the past decade, Middle East Pharmaceutical Industries Co's Dividend Payout Ratio has ranged from 0.19 to 0.70. According to the industry distribution chart, Middle East Pharmaceutical Industries Co ranks #363 out of 445 companies in the Drug Manufacturers industry, placing it in the top 81.6%.
Is Middle East Pharmaceutical Industries Co's Dividend Payout Ratio too high?
Middle East Pharmaceutical Industries Co's current Dividend Payout Ratio of 0.98 is 188% above median its 10-year median of 0.34. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 0.70. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Middle East Pharmaceutical Industries Co's value of 0.98 is 157.9% above this industry median. Based on the distribution chart, Middle East Pharmaceutical Industries Co ranks #363 out of 445 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Middle East Pharmaceutical Industries Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Middle East Pharmaceutical Industries Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Middle East Pharmaceutical Industries Co ranks #363 out of 445 companies for Dividend Payout Ratio. This places Middle East Pharmaceutical Industries Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Middle East Pharmaceutical Industries Co's value of 0.98 is 157.9% above this benchmark. Historically, Middle East Pharmaceutical Industries Co's own Dividend Payout Ratio has ranged from 0.19 to 0.70 over the past decade. While the company's 10-year median is 0.34 vs. the industry median of 0.38, Middle East Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Pharmaceutical Industries Co's current Dividend Payout Ratio of 0.98 is 157.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Middle East Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Pharmaceutical Industries Co's current Dividend Payout Ratio is 0.98, which is 188% above median its own 10-year median of 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Pharmaceutical Industries Co stock overvalued right now?
Middle East Pharmaceutical Industries Co (SAU:4016) has a current Dividend Payout Ratio of 0.98. The current Dividend Payout Ratio is 0.98, which is 188% above median its 10-year median of 0.34 and 157.9% above the Drug Manufacturers industry median of 0.38. Middle East Pharmaceutical Industries Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Middle East Pharmaceutical Industries Co (SAU:4016), the current Dividend Payout Ratio is 0.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Middle East Pharmaceutical Industries Co Business Description
Middle East Pharmaceutical Industries Co is a holding company engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments. Geographically, it generates the majority of its revenue from Saudi Arabia.
22GF Score
Get the complete analysis for SAU:4016
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4016 has been successfully added to your 
